133 related articles for article (PubMed ID: 24030923)
1. Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: an overview.
Toda N; Okamura T
J Clin Pharmacol; 2013 Dec; 53(12):1228-39. PubMed ID: 24030923
[TBL] [Abstract][Full Text] [Related]
2. Exercise training improves in vivo endothelial repair capacity of early endothelial progenitor cells in subjects with metabolic syndrome.
Sonnenschein K; Horváth T; Mueller M; Markowski A; Siegmund T; Jacob C; Drexler H; Landmesser U
Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):406-14. PubMed ID: 21450652
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
4. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
Tack CJ; Ong MK; Lutterman JA; Smits P
Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
Rask-Madsen C; King GL
Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
[TBL] [Abstract][Full Text] [Related]
6. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.
van Etten RW; de Koning EJ; Verhaar MC; Gaillard CA; Rabelink TJ
Diabetologia; 2002 Jul; 45(7):1004-10. PubMed ID: 12136399
[TBL] [Abstract][Full Text] [Related]
7. The vascular endothelin system in obesity and type 2 diabetes: pathophysiology and therapeutic implications.
Campia U; Tesauro M; Di Daniele N; Cardillo C
Life Sci; 2014 Nov; 118(2):149-55. PubMed ID: 24607780
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction, obesity and insulin resistance.
Prieto D; Contreras C; Sánchez A
Curr Vasc Pharmacol; 2014 May; 12(3):412-26. PubMed ID: 24846231
[TBL] [Abstract][Full Text] [Related]
9. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
Gupta S; Wright HM
Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
[TBL] [Abstract][Full Text] [Related]
10. Obesity up-regulates intermediate conductance calcium-activated potassium channels and myoendothelial gap junctions to maintain endothelial vasodilator function.
Chadha PS; Haddock RE; Howitt L; Morris MJ; Murphy TV; Grayson TH; Sandow SL
J Pharmacol Exp Ther; 2010 Nov; 335(2):284-93. PubMed ID: 20671071
[TBL] [Abstract][Full Text] [Related]
11. Alteration of nitric oxide-mediated blood flow regulation in diabetes mellitus.
Toda N; Imamura T; Okamura T
Pharmacol Ther; 2010 Sep; 127(3):189-209. PubMed ID: 20546780
[TBL] [Abstract][Full Text] [Related]
12. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
Michel JB
Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial dysfunction tested by blunted response to endothelium-dependent vasodilation by salbutamol and its related factors in uncomplicated pre-menopausal obese women.
Suh HS; Park YW; Kang JH; Lee SH; Lee HS; Shim KW
Int J Obes (Lond); 2005 Feb; 29(2):217-22. PubMed ID: 15570314
[TBL] [Abstract][Full Text] [Related]
14. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
15. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans.
Williams IL; Wheatcroft SB; Shah AM; Kearney MT
Int J Obes Relat Metab Disord; 2002 Jun; 26(6):754-64. PubMed ID: 12037644
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y
Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373
[TBL] [Abstract][Full Text] [Related]
17. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
Shemyakin A; Kövamees O; Rafnsson A; Böhm F; Svenarud P; Settergren M; Jung C; Pernow J
Circulation; 2012 Dec; 126(25):2943-50. PubMed ID: 23183942
[TBL] [Abstract][Full Text] [Related]
18. [Obesity and endothelial dysfunction].
Taddei S; Ghiadoni L; Salvetti G; Virdis A; Salvetti A
G Ital Cardiol (Rome); 2006 Nov; 7(11):715-23. PubMed ID: 17216913
[TBL] [Abstract][Full Text] [Related]
19. Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production.
Shinozaki K; Nishio Y; Ayajiki K; Yoshida Y; Masada M; Kashiwagi A; Okamura T
J Cardiovasc Pharmacol; 2007 Mar; 49(3):122-30. PubMed ID: 17414223
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide--the endothelium-derived relaxing factor and its role in endothelial functions.
Bauer V; Sotníková R
Gen Physiol Biophys; 2010 Dec; 29(4):319-40. PubMed ID: 21156995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
